EP 3906025 A4 20220921 - TOPICAL FORMULATIONS HAVING CANNABINOID
Title (en)
TOPICAL FORMULATIONS HAVING CANNABINOID
Title (de)
TOPISCHE FORMULIERUNGEN MIT CANNABINOID
Title (fr)
FORMULATIONS TOPIQUES COMPRENANT UN CANNABINOÏDE
Publication
Application
Priority
- US 201962788494 P 20190104
- US 2020012187 W 20200103
Abstract (en)
[origin: WO2020142692A1] Disclosed are cannabinoid formulations and methods of use associated therewith. Specifically, disclosed are topical or transdermal formulations having a cannabinoid in combination with a phyto-compound excipient that facilitates absorption and bioavailability of the cannabinoid.
IPC 8 full level
A61K 31/352 (2006.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01); A61K 31/05 (2006.01); A61K 36/185 (2006.01); A61K 36/67 (2006.01); A61K 36/81 (2006.01); A61K 38/48 (2006.01); A61M 11/00 (2006.01); A61P 17/00 (2006.01); A61P 25/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 9/0014 (2013.01); A61K 9/124 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 36/185 (2013.01); A61K 36/67 (2013.01); A61K 36/81 (2013.01); A61K 38/4873 (2013.01); A61P 17/00 (2017.12); A61P 25/00 (2017.12); A61P 35/00 (2017.12); C12Y 304/22002 (2013.01); A61M 11/00 (2013.01); A61M 2210/04 (2013.01)
Citation (search report)
- [XY] US 2016309774 A1 20161027 - WAND MICHAEL D [US]
- [XY] WO 2018236957 A1 20181227 - NEXIEN BIOPHARMA INC [US]
- [XY] WO 2018023164 A1 20180208 - ZELDA THERAPEUTICS OPERATIONS PTY LTD [AU]
- [XY] WO 2015200049 A1 20151230 - ISLAND BREEZE SYSTEMS CA LLC [US]
- [XY] CHERNIAKOV IRINA ET AL: "Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 266, 8 September 2017 (2017-09-08), pages 1 - 7, XP085292686, ISSN: 0168-3659, DOI: 10.1016/J.JCONREL.2017.09.011
- [A] P K LAKSHMI ET AL: "OILS AS PENETRATION ENHANCERS FOR IMPROVED TRANSDERMAL DRUG DELIVERY: A REVIEW", INTERNATIONAL RESEARCH JOURNAL OF PHARMACY, vol. 8, no. 4, 30 May 2017 (2017-05-30), pages 9 - 17, XP055949663, Retrieved from the Internet <URL:http://www.irjponline.com/admin/php/uploads/2645_pdf.pdf> DOI: 10.7897/2230-8407.080440
- See references of WO 2020142692A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2020142692 A1 20200709; EP 3906025 A1 20211110; EP 3906025 A4 20220921
DOCDB simple family (application)
US 2020012187 W 20200103; EP 20736215 A 20200103